Jim Cramer has said many times that his opinions and The Streets opinions are two separate things. He works for The Street, but he is not The Street.
Rickarooster comes out whenever there is a downturn. He seems to feed off the falling price and spew out anything negative he can think of. I wouldn't be surprised if he had other aliases not mentioned. He may be a paid shill of the professional shorts. Perhaps his presence is an indicator of a bottoming in the market that is driving everything down...
He said it after the conference call. Also the Street articles say "we rate SGEN a sell". Look up what the Street has to say about SGEN in your search. I think I read it right below the news on the stock symbol once but verified it again in my search. You don't have to go by what they say. The negative EPS shows right on the stock so that means they are bleeding money. That number is supposed to be on the positive side.
SILVER-Are you still out there? Did you buy HCP when I mentioned it on this board? Did anyone else? It may still go up but I sold today. Nice run-up when I posted interest rates were going to stay low. I suggested swapping out of SGEN and buying HCP with that great dividend and SILVER replied but haven't heard from you since.
Finally I am not being bashed and someone else thinks SGEN is not all that it was cracked up to be. I have not had anyone agree with me but now some are coming out of the woodwork. I just think there are plenty other stocks out there that aren't so deceiving as SGEN where the insiders are taking all the money from the company. Have I been wrong about any of my posts? This is still in a downward spiral hitting a 52 week low with more room to go. -
One thing I have learned in the Bio Techs is just buy the leaders like GILD, BIIB, AMGN, CELG and RGEN and let the spec plays go. I have lost a lot on SGEN and others but thinking they were long term plays. They always bite you in the a$$
No argument. Financial analysts also feel this way. Without an income stream they can't provide an accurate price projection.
You are so wrong. I don't know who those other people are but you seem to be long on this stock and losing so you say anyone posting negative remarks are the same person. Any response from Maui and fishman? How do we convince him we are not the same person?
All readers of this message board should know that fstout57, mauihope and fishman328 are the same troll - the one more widely known as rickarooski. This is a very sick individual who brings his various aliases to this board only when the stock falters, uses different 'voices' and approaches for each alias, and often engages in conversations with himself.
SGEN was long overdue for a pullback. Longs preaching $50 just around the corner were too sure of this little stock.... I went through the exact same thing when IMGN hit $45 one day many years ago. I wonder how many people lost their shirts betting on that $50 next month.
I remain long IMGN and SGEN but still not understanding why SGEN raced to $40 leaving IMGN struggling to hit $17.
I'm interested in how you quantify a good working relationship with the FDA? IMGN has been working with FDA far longer than SGEN, even with the long time industry professionals from Roche, they could not get faster approval for Kadcyla which keeps getting better results for each and every study. You would think a good working relationship would mean quick approvals for kadcyla in the other indications but there really is no difference whatsoever.
Everyone must get in line, follow the protocols and wait. Your implication that SGEN might somehow get approvals quicker is simply untrue.
Okay llabtech-The day I told you to buy this 14,305,000 shares traded hands. The stock closed at $3.50. I said to buy a few thousand shares and you said you bought per your reply dated the 14th. I said to cash out quick on the hype because all these were scams. It moved up to $4.55 July 28th-you bought on July 14th. Did you cash out like I said or wait until it hit 1.55 and lose? I have been doing this since 1987 and know how to make a quick profit by now. I don't wait for a huge return because things can get quite ugly in a hurry just like SGEN.
One more thing. Click on competitors. See the net income line for SGEN at -73.25m. Wow is all I can say compared to PFE on the plus side with 10.37 billion with a dividend to boot. Now which would you rather own? I prefer PFE who is making money and paying you each qtr. You can buy their shares cheaper than a company who is losing money. A no brainer?
Well they should have when I said to sell this thing when it was around $40.50. People have since bought 2000 shares when it was 36-37 only to be in the hole 6-7 thousand dollars in less than 2 weeks. Give me one good reason to buy this when the Washington Post said NW Bios are going down with a huge short interest. Did you see the shorts on SGEN?
Proposed for discussion: Clay Siegall, who has brought SGEN very far in recent years and deserves credit for that, should be retained as chief science officer but replaced as CEO. In many cases, the skills that were valuable in creating and building a company do not transfer into taking the company to the next level. This could be the case here. Time and again, he and his people shoot themselves in the feet when dealing with analysts and investors, and we all get caught in the crossfire. Most recently, advised by some of the least competent media and investor relations people I've ever seen, he allowed speculation to build during the weekend about the AETHERA results, did not bother to brief reporters about what was coming (particularly the OS angle), allowed a not-entirely-clear press release to be issued on Monday, and followed that with a disastrously mishandled conference call that was idiotically scheduled to begin at 5 a.m. local time, when mental fuzziness contributed to the disaster. The Bakers and other large investors should seriously consider bringing in a seasoned CEO to run this company before this sort of thing is happens yet again. Let the debate begin...
is now rating this stock a sell. He was hyping this thing in the 40's but when the latest report came out with negative news that the "wonder" drug showed no effect, he changed course and said SELL. Now SGEN needs to pump a new drug and start all over again. Notice Cramer never said "sorry I was wrong about this stock" as usual. I am sure he sold way before this.